Skip to content
healthcare.dev

Duloxetine Delayed-Release

NDC 68001-368, DULOXETINE HYDROCHLORIDE, capsule, delayed release pellets, from BluePoint Laboratories.

Product NDC
68001-368
Status
Listed
Labeler
BluePoint Laboratories
Dosage form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203088
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68001-368 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DULOXETINE HYDROCHLORIDE40 mg/1

Pharmacologic classes

Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]

Package NDCNDC-11Package
68001-368-046800103680430 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (68001-368-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a95cc04c-58e9-487f-8992-ef30df03a3cd

Use it

Look up 68001-368 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68001-368 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68001-368. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.